Board ChairPlasminogen Deficiency FoundationDurham, North Carolina, United States
PB0229 - DESIGNING THE RYPLAZIM® (PLASMINOGEN, HUMAN-tvmh) ARM OF ATHN TRANSENDS: SAFETY AND EFFECTIVENESS IN PEOPLE WITH PLASMINOGEN DEFICIENCY
Sunday, June 25, 202318:30 – 19:30 ET
